Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
13-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
13-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #27449
advertisement
Jansonius NM
4
Showing records 1 to 4 |
Display all abstracts from
Jansonius NM
47734
Defining glaucomatous optic neuropathy from a continuous measure of optic nerve damage the optimal cut-off point for risk-factor analysis in population-based epidemiology
Ramdas WD; Rizopoulos D; Wolfs RCW; Hofman A; de Jong PTVM; Vingerling JR; Jansonius NM
Ophthalmic Epidemiology
2011; 18: 211-216
48062
Incorporating life expectancy in glaucoma care
Wesselink C; Stoutenbeek R; Jansonius NM
Eye
2011; 25: 1575-1580
47733
Heidelberg Retina Tomograph (HRT3) in population-based epidemiology: Normative values and criteria for glaucomatous optic neuropathy
Ramdas WD; Wolfs RCW; Hofman A; de Jong PTVM; Vingerling JR; Jansonius NM
Ophthalmic Epidemiology
2011; 18: 198-210
47980
Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study
Ramdas WD; Wolfs RC; Hofman A; De Jong PT; Vingerling JR; Jansonius NM
Investigative ophthalmology & visual science
2011; 52: 6875-6881
Issue
13-4
Table of Contents
Editor's Selection
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept